;

Articles Not Curated - Immunology
Last updated: 2025 Mar 18
Total hit(s): 35899
S.No.
1
40338231
Assessing vaccine coverage and delivery strategies for influenza and COVID-19 among Italian healthcare workers: A 2015-2023 case study.
Hum Vaccin Immunother
2025 Dec
4.7
1
2
40497727
The effect of SARS-CoV-2 and influenza vaccination on endemic coronavirus-related mortality: A retrospective cohort study in Brazil.
Hum Vaccin Immunother
2025 Dec
4.7
1
3
40197159
SARS-CoV-2 epidemiology, kinetics, and evolution: A narrative review.
Virulence
2025 Dec
4.81
1
4
40376714
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial.
Hum Vaccin Immunother
2025 Dec
4.7
1
5
40214651
From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine.
Hum Vaccin Immunother
2025 Dec
4.7
1
6
40179339
Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022-2023.
Hum Vaccin Immunother
2025 Dec
4.7
1
7
40163329
COVID-19 vaccine confidence among parents of racially diverse children aged 0-12 years old in Canada: The role of major experience of racial discrimination, health literacy, and conspiracy beliefs.
Hum Vaccin Immunother
2025 Dec
4.7
1
8
40156199
COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community setting.
Hum Vaccin Immunother
2025 Dec
4.7
1
9
40137440
Protection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong.
Expert Rev Vaccines
2025 Dec
4.37
1
10
40135763
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies.
Ann Med
2025 Dec
3.01
1
11
40134119
Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic.
Hum Vaccin Immunother
2025 Dec
4.7
1
12
40195167
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study.
Expert Rev Vaccines
2025 Dec
4.37
1
13
40356453
Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in Mexico.
Expert Rev Vaccines
2025 Dec
4.37
1
14
40366666
A four-week study on the toxicity of repeated intramuscular administration of plant-based BA-CoV2-0301 vaccine against SARS-CoV-2 in Sprague-Dawley rats.
J Immunotoxicol
2025 Dec
1
15
40028815
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.
Hum Vaccin Immunother
2025 Dec
4.7
1
16
40045463
The characterization of technical design of a virus-like structure (VLS) nanodelivery system as vaccine candidate against SARS-CoV-2 variants.
Hum Vaccin Immunother
2025 Dec
4.7
1
17
40051347
Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection.
Hum Vaccin Immunother
2025 Dec
4.7
1
18
40068961
Impact of COVID-19 pandemic on influenza vaccination rates among healthcare workers and the general population in Saudi Arabia: A meta-analysis.
Hum Vaccin Immunother
2025 Dec
4.7
1
19
40382340
Increased dialysis symptom index burden in maintenance hemodialysis patients during the COVID-19 lockdown period.
Ann Med
2025 Dec
3.01
1
20
40329514
Integrating immune library probing with structure-based computational design to develop potent neutralizing nanobodies against emerging SARS-CoV-2 variants.
MAbs
2025 Dec
10
1
21
40079963
Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review.
Hum Vaccin Immunother
2025 Dec
4.7
1
22
39834144
Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variants.
Expert Rev Vaccines
2025 Dec
4.37
1
23
40432512
Neutralizing antibody levels as a key factor in determining the immunogenic efficacy of the novel PEDV alpha coronavirus vaccine.
Vet Q
2025 Dec
8.5
1
24
39865693
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.
Hum Vaccin Immunother
2025 Dec
4.7
1
25
39898697
Acceptance and attitudes towards COVID-19 vaccination during pregnancy in Canada.
Hum Vaccin Immunother
2025 Dec
4.7
1